Published online Aug 16, 2021. doi: 10.4253/wjge.v13.i8.319
Peer-review started: February 18, 2021
First decision: March 14, 2021
Revised: March 21, 2021
Accepted: July 14, 2021
Article in press: July 14, 2021
Published online: August 16, 2021
Processing time: 174 Days and 23.2 Hours
Thoracoscopic esophagectomy is related to an extended lymphadenectomy, and a high number of retrieved lymph nodes, compared to the transhiatal approach; however, its association with an improvement in overall survival (OS) is debatable.
To compare thoracoscopic esophagectomy with transhiatal esophagectomy in patients with adenocarcinoma of the esophagogastric junction (AEGJ) in terms of survival, number of lymph nodes, and complications.
In total, 147 patients with AEGJ were selected retrospectively from 2002 to 2019, and divided into Group A for thoracoscopic esophagectomy, and group B for transhiatal esophagectomy. OS, disease-free survival, postoperative complications, and number of nodes, were similarly evaluated.
One hundred and thirty (88%) were male; the mean age was 64 years. Group A had a mean age of 61.1 years and group B 65.7 years (P = 0.009). Concerning the extent of lymphadenectomy, group A showed a higher number of retrieved lymph nodes (mean of 31.89 ± 8.2 vs 20.73 ± 7; P < 0.001), with more perioperative complications, such as hoarseness, surgical site infections, and respiratory complications. Although both groups had similar OS rates, subgroup analysis showed better survival of transthoracic esophagectomy in patients with earlier diseases.
Both methods are safe, having similar morbidity and mortality rates. Transthoracic thoracoscopic esophagectomy allows a more extensive resection of the lymph nodes and may have better oncological outcomes during earlier stages of the disease. Prospective studies are warranted to better evaluate these findings.
Core Tip: The type of access during esophagectomy to adenocarcinoma of esophagogastric junction tumor is on debate. Thoracoscopic esophagectomy produces higher numbers of retrieved lymph nodes than transhiatal esophagectomy but is associated with more perioperative complications. The relationship between lymphadenectomy’s extension and survival outcomes is debatable. We compared both access and found better survival in early staging of patients treated by thoracoscopic esophagectomy, probably due to the extension of lymphadenectomy and acceptable complication rate. These findings reveal a new place of thoracoscopic esophagectomy for adenocarcinoma of the esophagogastric junction tumor in the multimodal era.